ruxolitinib
novartis,incyte
['ruxolitinib', 'rux,(-crux),(-trux),(-deruxtecan)']
#ash22 session 722: filling the gaps on gvhd in pediatric patients prof. locatelli presents preliminary data of the phase i/ii reach4 study: ruxolitinib in pediatric pts with treatment-na ve or steroid-refractory agvhd 
MD @ClevelandClinic @unitorvergata | Lymphoma survivor#Resilient | MDS/AML/APL/Bone marrow failure syndromes| Member @TheEBMT_Trainee | Opinions are my own